Chongguo Zhang

672 total citations
8 papers, 474 citations indexed

About

Chongguo Zhang is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Chongguo Zhang has authored 8 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Cancer Research and 1 paper in Surgery. Recurrent topics in Chongguo Zhang's work include Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (6 papers) and RNA Research and Splicing (3 papers). Chongguo Zhang is often cited by papers focused on Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (6 papers) and RNA Research and Splicing (3 papers). Chongguo Zhang collaborates with scholars based in China. Chongguo Zhang's co-authors include Xuezhi He, Dandan Yin, Liang Han, Erbao Zhang, Xiyi Lu, Wei De, Jun Su, Jinfei Chen, Xinxin Si and Juan Wang and has published in prestigious journals such as Cancer Research, Genome biology and Cell Death and Disease.

In The Last Decade

Chongguo Zhang

8 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chongguo Zhang China 7 414 366 43 35 34 8 474
Haiou Hong China 5 398 1.0× 195 0.5× 67 1.6× 19 0.5× 46 1.4× 10 459
Guozhi Yin China 13 275 0.7× 236 0.6× 41 1.0× 58 1.7× 18 0.5× 19 371
Hanyu Ma China 7 284 0.7× 283 0.8× 27 0.6× 34 1.0× 31 0.9× 14 383
Jiaomeng Pan China 6 242 0.6× 218 0.6× 24 0.6× 51 1.5× 32 0.9× 8 354
Zhongbo Han China 6 325 0.8× 312 0.9× 39 0.9× 37 1.1× 37 1.1× 13 418
Shoumei Yang China 6 225 0.5× 172 0.5× 29 0.7× 48 1.4× 25 0.7× 8 296
Qinliang Fang China 10 356 0.9× 252 0.7× 22 0.5× 62 1.8× 54 1.6× 15 442
Liutao Chen China 7 445 1.1× 230 0.6× 19 0.4× 51 1.5× 53 1.6× 7 511

Countries citing papers authored by Chongguo Zhang

Since Specialization
Citations

This map shows the geographic impact of Chongguo Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chongguo Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chongguo Zhang more than expected).

Fields of papers citing papers by Chongguo Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chongguo Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chongguo Zhang. The network helps show where Chongguo Zhang may publish in the future.

Co-authorship network of co-authors of Chongguo Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Chongguo Zhang. A scholar is included among the top collaborators of Chongguo Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chongguo Zhang. Chongguo Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Zhu, Qingqing, Chongguo Zhang, Tianyu Qu, et al.. (2022). MNX1-AS1 Promotes Phase Separation of IGF2BP1 to Drive c-Myc–Mediated Cell-Cycle Progression and Proliferation in Lung Cancer. Cancer Research. 82(23). 4340–4358. 65 indexed citations
2.
Ding, Yue, Yan Zhuang, Chongguo Zhang, et al.. (2022). Copy number amplification-activated long non-coding RNA LINC00662 epigenetically inhibits BIK by interacting with EZH2 to regulate tumorigenesis in non-small cell lung cancer. Journal of Cancer. 13(5). 1640–1651. 2 indexed citations
3.
Zhu, Liangjun, Chongguo Zhang, Jiao Xue, et al.. (2021). EZH2-mediated epigenetic suppression of lncRNA PCAT18 predicts a poor prognosis and regulates the expression of p16 by interacting with miR-570a-3p in gastric cancer. Journal of Cancer. 12(23). 7069–7078. 8 indexed citations
4.
Su, Jun, Bo Yu, Chongguo Zhang, et al.. (2020). Long noncoding RNA HOXC-AS3 indicates a poor prognosis and regulates tumorigenesis by binding to YBX1 in breast cancer.. PubMed. 12(10). 6335–6350. 12 indexed citations
5.
Wang, Ni, Chongguo Zhang, Wulin Wang, et al.. (2019). Long noncoding RNA DANCR regulates proliferation and migration by epigenetically silencing FBP1 in tumorigenesis of cholangiocarcinoma. Cell Death and Disease. 10(8). 585–585. 41 indexed citations
6.
Hui, Bingqing, Hao Ji, Yetao Xu, et al.. (2019). RREB1-induced upregulation of the lncRNA AGAP2-AS1 regulates the proliferation and migration of pancreatic cancer partly through suppressing ANKRD1 and ANGPTL4. Cell Death and Disease. 10(3). 207–207. 86 indexed citations
7.
Zhang, Erbao, Xuezhi He, Chongguo Zhang, et al.. (2018). A novel long noncoding RNA HOXC-AS3 mediates tumorigenesis of gastric cancer by binding to YBX1. Genome biology. 19(1). 154–154. 221 indexed citations
8.
Yao, Min, Dengfu Yao, Yinzhu Bian, et al.. (2011). Oncofetal antigen glypican-3 as a promising early diagnostic marker for hepatocellular carcinoma. Hepatobiliary & pancreatic diseases international. 10(3). 289–294. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026